Arcellx (ACLX) Earnings Date & Reports

Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

ACLX is expected to report earnings to fall 7.96% to -103 cents per share on August 18

Q2'25

Est.

$-1.04

Q1'25

Missed

by $0.37

Q4'24

Missed

by $0.31

Q3'24

Missed

by $0.14

Q2'24

Beat

by $0.01

The last earnings report on May 08 showed earnings per share of -112 cents, missing the estimate of -75 cents. With 627.24K shares outstanding, the current market capitalization sits at 3.24B.

View a ticker or compare two or three

Compare

ACLX